{
    "2019-01-10": [
        [
            {
                "time": "2023-10-19",
                "original_text": "European ADRs Move Higher in Thursday Trading",
                "features": {
                    "keywords": [
                        "European",
                        "ADRs",
                        "Move Higher",
                        "Thursday Trading"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "international markets"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-19",
                "original_text": "Implied FVD Analyst Target Price: $34",
                "features": {
                    "keywords": [
                        "FVD",
                        "Analyst",
                        "Target Price",
                        "$34"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "stocks",
                        "valuation"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-19",
                "original_text": "Novartis migraine drug not cost effective - U.K. price watchdog",
                "features": {
                    "keywords": [
                        "Novartis",
                        "migraine drug",
                        "cost effective",
                        "U.K.",
                        "price watchdog"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}